Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A phase 2 trial evaluating the combination of bendamustine hydrochloride, bortezomib, and dexamethasone in newly diagnosed multiple myeloma …
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma [Phase 1]
Phase 1 clinical trial update on AR-42 in adults with advanced or relapsed multiple myeloma, chronic lymphocytic leukemia, and various lymph…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant [Phase 2]
Phase 2 trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for multiple myeloma after allogeneic transplant was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands [Phase 1]
Phase 1 safety study of CYAD-01, CAR T cells targeting NKG2D-ligands, completed; evaluated in acute myeloid leukemia, myelodysplastic syndro…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma [Phase 2]
Phase 2 trial investigating MEDI-551 as maintenance therapy after allogeneic stem cell transplantation in multiple myeloma; study terminated…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1]
A Phase 1 study evaluating a regimen of bortezomib, melphalan, and total-body irradiation before stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma [Phase 1]
Phase 1 trial evaluating Nivolumab for patients with refractory or relapsed multiple myeloma; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease
This clinical trial update reports results from a retrospective chart review of second-line lenalidomide/dexamethasone therapy and treatment…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating panobinostat with everolimus in recurrent hematologic malignancies including multiple myeloma and non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib [Phase 2]
Phase 2 study assessing efficacy and safety of pomalidomide plus dexamethasone in patients with multiple myeloma who relapsed after lenalido…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols [Phase 2]
A Phase 2 study evaluated extending carfilzomib therapy in patients previously enrolled in carfilzomib treatment protocols. The trial has co…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma [Phase 1]
Phase 1 trial evaluating Rituximab, Yttrium Y-90 ibritumomab tiuxetan, and Melphalan with autologous stem cell transplant in patients with p…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating dinaciclib in combination with bortezomib and dexamethasone in relapsed plasma cell myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: A Study of VLX1570 and Dexamethasone in Myeloma Patients [Phase 1, Phase 2]
A phase 1/2 study of VLX1570 in combination with dexamethasone for multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial update on safety and dosing for BT062 in patients with relapsed or refractory multiple myeloma; study completed with results…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy [NA]
Clinical trial evaluating the efficacy of an intraoperative gamma camera with lymphoscintigraphy to identify sentinel lymph nodes in breast …
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Phase 1, Phase 2]
A phase 1/2 trial of Clofarabine combined with non-myeloablative allogeneic hematopoietic transplantation was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF [Phase 1]
Phase 1 study evaluating mobilization of autologous peripheral blood stem cells using interleukin-2 and GM-CSF; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM) [Phase 2]
Phase II, single-center study evaluating a combination of panobinostat, lenalidomide, and dexamethasone in multiple myeloma; results were po…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: To Compare Conservative Management Vs. Balloon Kyphoplasty in the Treatment of VCFs in Patients With Multiple Myeloma [NA]
A clinical trial comparing conservative management to balloon kyphoplasty for vertebral compression fractures in patients with multiple myel…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
This completed clinical trial update evaluates the prognostic potential of cell surface markers and Pim kinase expression in multiple myelom…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Vinorelbine and Gemcitabine in Myeloma [Phase 2]
A Phase 2 clinical trial evaluating vinorelbine and gemcitabine in patients with multiple myeloma (and amyloidosis) has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant [Phase 1]
A Phase 1 trial from Massachusetts General Hospital evaluating recipient leukocyte infusions to prevent donor graft rejection after nonmyelo…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma [Phase 2]
Phase 2 study evaluating daratumumab monotherapy and its effects on bone parameters in patients with relapsed or refractory multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan [Phase 2]
Phase II study of lenalidomide/dexamethasone with or without elotuzumab in newly diagnosed multiple myeloma patients in Japan completed with…